If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
252.80    4.40 (1.77%)
Bid:
252.00
Ask:
252.80
Spread: 0.80 (0.317%)
Market Cap: £637.25m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

6 Oct 2023 15:59

RNS Number : 0314P
Genuit Group PLC
06 October 2023
 

Genuit Group plc (the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

The Company announces that on 29 September 2023, Emma Versluys, Group Legal Counsel and Company Secretary and a Person Discharging Managerial Responsibilities, exercised the following options:

 

1. a nil-cost option over 5,973 shares in accordance with the Long-Term Incentive Plan Award granted on 22 May 2017. Ms. Versluys sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise;

 

2. a nil-cost option over 3,508 shares in accordance with the Long-Term Incentive Plan Award granted on 2 May 2018. Ms. Versluys sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise; and

 

3. a nil-cost option over 4,108 shares in accordance with the Long-Term Incentive Plan Award granted on 30 April 2019. Ms. Versluys sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Emma Versluys

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Legal Counsel and Company Secretary

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of £0.001 each in the capital of Genuit Group plc ("Shares")

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options as follows:

- Long-Term Incentive Plan ("LTIP") award granted on 22 May 2017

- LTIP award granted on 2 May 2018

- LTIP award granted on 30 April 2019

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

2,966 - Number of Shares acquired from 22 May 2017 LTIP award after reduction for appropriate tax and national insurance

liabilities.

1,742 - Number of Shares acquired from 2 May 2018 LTIP award after reduction for appropriate tax and national insurance

liabilities.

2,040 - Number of Shares acquired from 30 April 2019 LTIP award after reduction for appropriate tax and national insurance

liabilities.

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

e)

 

Date of the transaction

 

 

4 October 2023

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

Enquiries:

Colette Thompson, Assistant Company Secretary

 

+44 (0) 1138 315 315

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKABPQBDDOKK
Date   Source Headline
7th Oct 20244:05 pmRNSHolding(s) in Company
9th Sep 20245:13 pmRNSHolding(s) in Company
6th Sep 20244:46 pmRNSHolding(s) in Company
20th Aug 20244:26 pmRNSDirector/PDMR Shareholding
13th Aug 20247:00 amRNSHalf-year Report
8th Aug 20247:00 amRNSBlue green roof & underfloor heating acquisitions
7th Aug 20247:00 amRNSAppointment of Joint Corporate Broker
10th Jun 20244:34 pmRNSHolding(s) in Company
10th Jun 20244:32 pmRNSHolding(s) in Company
28th May 20242:14 pmRNSResult of AGM
28th May 20247:00 amRNSTrading Update
2nd May 20244:57 pmRNSBlock listing Interim Review
24th Apr 202410:39 amRNSNotice of AGM
10th Apr 20244:24 pmRNSDirector/PDMR Shareholding
10th Apr 20244:17 pmRNSDirector/PDMR Shareholding
9th Apr 20244:28 pmRNSDirector Declaration
2nd Apr 20243:56 pmRNSDirector/PDMR Shareholding
20th Mar 20243:27 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFinal Results
1st Mar 20248:30 amRNSDirector Declaration
19th Feb 20249:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20243:49 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSStrategy Progress Update Notification
15th Nov 20237:00 amRNSTrading Update
9th Nov 202310:08 amRNSDirector Declaration
2nd Nov 202311:59 amRNSDirector/PDMR Shareholding
1st Nov 20234:00 pmRNSBlock listing Interim Review
1st Nov 20237:00 amRNSDirectorate Change
25th Oct 20234:04 pmRNSDirector/PDMR Shareholding
17th Oct 20234:05 pmRNSDirector/PDMR Shareholding
11th Oct 20233:25 pmRNSDirector/PDMR Shareholding
6th Oct 20233:59 pmRNSDirector/PDMR Shareholding
11th Sep 202312:56 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Chief Financial Officer appointment
23rd Aug 20231:34 pmRNSDirector/PDMR Shareholding
18th Aug 202312:14 pmRNSDirector/PDMR Shareholding
16th Aug 202311:42 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSHalf-year Report
27th Jun 202312:01 pmRNSDirector/PDMR Shareholding
12th Jun 20234:11 pmRNSDirectorate Change
6th Jun 20237:00 amRNSDirectorate Change
18th May 202311:40 amRNSResult of AGM
18th May 20237:00 amRNSTrading Update
2nd May 20239:38 amRNSBlock listing Interim Review
25th Apr 20234:19 pmRNSDirector/PDMR Shareholding
25th Apr 20234:16 pmRNSDirector/PDMR Shareholding
18th Apr 202310:49 amRNSNotice of AGM
13th Apr 20233:57 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
31st Mar 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.